# Zimmer Biomet to acquire Embody for up to $275 million

Zimmer Biomet has reached a definitive agreement to acquire Embody, a medical device company focused on soft tissue healing, for $155 million at closing plus up to $120 million in milestone payments. The acquisition strengthens Zimmer Biomet's sports medicine portfolio.

- Type: Acquisition
- Announced: 2023-01-05
- Where: Warsaw, Indiana, United States
- Value: $155.0M
- Status: announced
- Products: collagen-based biointegrative implants for tendon healing, arthroscopic implant systems for rotator cuff repair
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Zimmer Biomet](https://endata.com/companies/30687.md) (acquirer)
- [Embody Inc.](https://endata.com/companies/62122.md) (target)

## Sources

- [investor.zimmerbiomet.com](https://investor.zimmerbiomet.com/news-and-events/news/2023/01-05-2023-120317843), 2023-01-05: "The planned acquisition of Embody is an important step in the ongoing transformation of ZB and the execution of our strategic priority to increase long-term growth and drive value creation."
- [prnewswire.com](https://www.prnewswire.com/news-releases/zimmer-biomet-to-acquire-embody-inc-301714093.html), 2023-01-05: "The planned acquisition of Embody is an important step in the ongoing transformation of ZB and the execution of our strategic priority to increase long-term growth and drive value creation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.